Yale School of Medicine - Internal Medicine | Strategic Alliance Partners

Computer-aided detection during colonoscopies with AI may help increase adenoma detection rates.

The Pressure Check study at Yale aims to address disparities in blood pressure management.

Looking to the future of atopic dermatitis treatment, the panel discusses ongoing research and promising emerging therapies.

Focusing on clinical scenarios, experts on atopic dermatitis discuss how their treatment approaches vary depending on patient-specific factors.

Dermatologists outline the role of targeted therapies and JAK inhibitors in the treatment of patients with atopic dermatitis.

Following a review of findings from the LEVEL UP study, an expert on atopic dermatitis shares what we’ve learned from long-term data on upadacitinib and JAKi.

Jonathan Silverberg, MD, PhD, MPH, reviews findings from the LEVEL UP study investigating upadacitinib in patients with moderate-to-severe atopic dermatitis.

Lindsay S. Ackerman, MD, FAAD, and Jonathan Silverberg, MD, PhD, MPH, provide clinical insights on best practices for monitoring patients with atopic dermatitis who are receiving JAK inhibitors.

Experts on atopic dermatitis compare the safety profile of JAK inhibitors with traditional and more advanced treatments currently available for patients.

A panel of dermatologists discuss the evolution of JAK inhibitors for atopic dermatitis and how they fit into current treatment paradigms.

Focusing on the complex pathophysiology of atopic dermatitis, Lindsay S. Ackerman, MD, FAAD, discusses the importance of looking beyond type 2 inflammation while treating patients.

The expert panel concludes its discussion with insights on how collaboration and communication across various healthcare specialties improve the care of patients treated for iron deficiency anemia.

The panel discusses the mechanism of treatment-emergent hypophosphatemia that occurs following the administration of certain intravenous iron formulations.

Dermatologists outline unmet needs in the treatment landscape for atopic dermatitis and discuss how to potentially improve the standard of care for patients with atopic dermatitis.

The panel provides comprehensive insights on treating atopic dermatitis and how recent advances have elevated standard-of-care treatment practices in dermatology practices.

Experts on iron deficiency anemia discuss practical tools they utilize for the clinical administration of intravenous iron.

Steven Fein, MD, MPH, shares insights on the management of infusion reactions seen in patients receiving intravenous iron.

A panel of experts on atopic dermatitis discuss how patient preferences are taken into account when choosing between available treatments.

Jonathan Silverberg, MD, PhD, MPH, offers insights on the role of patient-reported outcomes in informing treatment decisions for patients with atopic dermatitis.

Layla Van Doren, MD, discusses the management of complement activation-related pseudo-allergy (CARPA) in patients receiving intravenous iron infusions.

A panel of experts on iron deficiency anemia discuss the safety of intravenous iron infusions, highlighting data from clinical studies.

Lindsay S. Ackerman, MD, FAAD, provides clinical insights on best practices for evaluating treatment response in patients with atopic dermatitis.

Lindsay S. Ackerman, MD, FAAD, and Jonathan Silverberg, MD, PhD, MPH, discuss how patient goals inform treatment decisions for patients with atopic dermatitis.

Experts on iron deficiency anemia share clinical practices for patients receiving intravenous iron.

Michael Auerbach, MD, provides an overview of the utility of generic formulations of iron in addressing iron deficiency anemia.

Experts on atopic dermatitis describe the burden of the disease and provide clinical insights on counseling patients who are experiencing sleep disturbances.

A panel of dermatologists discuss the heterogeneity of clinical presentations of atopic dermatitis and offer ways to reduce misdiagnosis.

A panel of experts on iron deficiency anemia discusses formulations available for iron infusions, highlighting factors that inform selection.

Experts in hematology, gastroenterology, and obstetrics and gynecology detail their experiences with the real-world application of intravenous iron in their clinics.

An obstetrician-gynecologist addresses the unmet clinical needs in the treatment of patients with iron deficiency anemia, particularly for pregnant patients.